Funding powers the next phase of growth with AI-driven customer engagement, onboarding innovation, and expansion upmarket

BOSTON, Nov. 12, 2025 — OnRamp, the Boston-based company behind the leading intelligent customer onboarding and engagement platform, today announced it has raised $15 million, completing its Series A funding, led by new investor Koch Disruptive Technologies (KDT), as well as contributions from existing venture capital investors Contour, Javelin, Pear and other investors. This brings the company’s total funding to $27 million. The company has achieved more than 100% year-over-year growth, driven by demand from market-leading companies.

OnRamp will use this funding to advance AI-powered capabilities for its customer engagement platform, scale its team, and deepen its roots in Boston’s technology ecosystem, opening 6,000 square feet of office space in early 2026.

“This investment marks an important day for OnRamp and for the customer engagement space,” said Paul Holder, OnRamp’s co-founder and CEO. “Having spent a decade working with customer success leaders at high-growth companies, I’ve seen firsthand how important it is to make a positive impact and build customer relationships from the start. This funding allows us to accelerate our AI-powered platform, expand our product and engineering teams, and deliver that impact at scale.”

Founded in 2020, OnRamp has quickly scaled, becoming a go-to solution for customer engagement, with three of the Fortune 15 companies as its primary enterprise customers. Since the company’s inception, customers have seen a 60% decrease in time to onboard, with some reporting a near 100% completion rate.

Alongside its recent funding, OnRamp launched AI Summaries in both the Insights and Views features, an intelligence layer that enhances data organization and visibility within its platform. The new capability uses AI to analyze any report for customers with written insights, recommendations and visualizations, automatically surfacing hidden patterns. This capability sets the foundation for a broader suite of intelligent, AI-powered onboarding functionality planned through the end of 2025 and into 2026.

“OnRamp has built a distinct, exceptional AI-enabled platform in this space, making it the leading solution for modern customer success teams looking to accelerate revenue and drive value,” said Brendon Durkin, Managing Director at Koch Disruptive Technologies. “Koch is thrilled to partner with OnRamp as they scale and redefine customer engagement on a global stage.”

Forrester notes that customer success teams are undergoing a full identity shift, from keeping customers happy, to driving real revenue.

Hundreds of companies rely on OnRamp to accelerate customer adoption, strengthen relationships, and turn success into a revenue engine. OnRamp’s platform powers engagement and onboarding workflows, allowing users to:

• Reduce churn
• Accelerate revenue realization
• Speed up time-to-value

“In just three months with OnRamp, we’ve doubled our onboarding capacity and cut our go-live time by more than half. We’re gaining access to valuable data that was previously out of reach,” said Brian Thome, Chief Customer Officer at Qualia. “The platform has made it possible to deliver a smooth, efficient onboarding experience while maintaining the high quality service our customers expect.”

Learn more at www.onramp.us

About OnRamp
Founded in 2020, OnRamp is the intelligent, AI-enabled customer onboarding and engagement platform that helps companies accelerate adoption, strengthen customer relationships, and unlock revenue growth. By eliminating onboarding bottlenecks, automating workflows, and providing visibility into progress, OnRamp enables enterprises to deliver value faster, reduce churn, and expand revenue opportunities. Backed by Koch Disruptive Technologies, Javelin Venture Partners, Contour Venture Partners, Pear VC, and other leading investors, OnRamp already serves multiple Fortune 15 companies and continues to help enterprises transform customer success into revenue growth.

SOURCE OnRamp Technology, Inc.

Built on Unified Visibility, RADAR’s AI Already Powers Leading Enterprises in CPG, Food, & Beyond

SANTA CLARA, Calif., Nov. 12, 2025 — Decklar (formerly Roambee) today announced the launch of RADAR (Real-time Alert Detection And Response), a next-generation, AI-native Logistics Control Tower Platform that unifies real-time visibility, predictive intelligence, and autonomous logistics execution. RADAR moves global supply chains beyond dashboards and exception monitoring, into an operating model where Decision AI continuously interprets what is happening, determines what must happen next, and initiates fast, auditable action—autonomously or in collaboration with humans.

The launch comes at a time when supply chain leaders face unprecedented volatility. A Deloitte survey referenced by Supply Chain Digital warns that, “76% of manufacturers say visibility across their supply chain is limited. In the past, this meant delayed shipments or missed deadlines. In 2025, it can mean reputational damage, compliance violations or multi-million-dollar losses.” The article further adds, “With those risks in mind, 55% of supply chain leaders are increasing tech investment and 60% plan to spend more than US$1m on solutions such as orchestrated visibility platforms, cloud computing, predictive analytics and AI. Companies like Lenovo are investing heavily in AI-driven supply chain capabilities, highlighting how urgently Global 2000 enterprises are modernizing visibility, planning, and execution.”

Most control towers software modules are offered by two categories of companies: supply chain planning (SCP) tools or real-time transport visibility platforms (RTTVPs) built on carrier and milestone data. The first group is strong as a System of Record but slow to act because they rely on periodic refreshes and manual intervention. The second sees movement but lacks verifiable & unified visibility, resulting in fragmented or delayed intelligence that cannot drive true real-time intervention. For years, enterprises relied on such control tower software or developed their own. Most still depend on human operators, planners, and GSOC-style teams to piece together context, escalate correctly, and enforce SOPs. As regulatory demands rise and shipment volumes surge, this human-dependent, polling-based model can no longer keep up.

RADAR is different. Built on unified visibility—streaming  track & trace, milestone data, carrier, environmental, and product behavior signals—it acts as a real-time System of Action that correlates events, anticipates risks, and executes the right response instantly. Its AI analyzes emerging patterns, classifies risks, anticipates disruptions, and determines the exact interventions required. From there, RADAR’s autonomous agents initiate the response—whether it is with AI voice calling a driver stopped at a high-risk zone, escalating to quality and security teams, enforcing lane-specific SOP violations, or routing decisions to the apprise internal owners with full context. The result is a level of unmatched speed, consistency, and accountability that manual control towers simply cannot achieve.

 “Visibility helped supply chains see, but visibility alone cannot operate a modern supply chain network,” said Sanjay Sharma, CEO of Decklar. “RADAR is the first AI-native Logistics Control Tower Platform built as a real-time System of Action for execution and intervention across 100% of the supply chain network. It understands what’s happening, knows what needs to happen next, and acts instantly including picking up the phone and having a conversation with vehicle operators or other supply chain stakeholders. This is the level of intelligence the next decade of supply chain resilience will be built on.”

Early enterprise deployments show the impact of this approach. A global chocolatier improved cold chain compliance from 57% to over 90% while avoiding an expensive transport infrastructure overhauls and strengthening retailer confidence in a region. A regulated global CPG leader brought its ocean network under real-time control across 120+ countries, reducing detention, demurrage, unnecessary air freight, and stockout risk. Across these networks, RADAR has unlocked more than $17 million in combined annual value in top and bottom lines for these companies. In pharma distribution, RADAR is configured to enable three times faster response to excursions and route deviations while reducing theft and temperature incidents dramatically.

RADAR is now available globally. To explore the platform in detail, download the RADAR Adoption Guide at www.decklar.com/ai-platform/radar. 

About Decklar
Decklar (formerly Roambee) pioneers Real-Time Decisions AI with Unified Visibility, reshaping the supply chains of Global 2000s to be transparent, automated, and sustainable. Within weeks, these enterprises transform key processes like replenishment, goods receipt, revenue forecasting, quality release, security, and asset management into dynamic, risk-informed operations. Despite over $25B spent globally on planning, TMS, and visibility tools, supply chains still stall: 60% of shipments arrive late, disrupting inventory plans; 17% face quality issues; and 76% of reusable assets go underutilized. Planning/TMS tools remain Systems of Record, relying on static or manual data. Visibility tools lack business context. Decklar closes this gap.

Built on 10+ years self-enriching supply chain visibility data, the Decklar’s AI-native platform fuses real-time shipment and asset signals with Decision Intelligence—delivering precise execution and planning recommendations for Supply Chain, Logistics, Quality, Security, Operations, and Finance—functioning as a System of Action. Decklar’s Real-Time Decisions AI now powers over 42% of U.S. pharmaceutical shipments, more than 66% of South Asia’s confectionery, and about a quarter of global CPG shipments—measurably boosting top and bottom lines. Know more at https://www.decklar.com.

Media Contact
Premsai Sainathan
Vice President – Growth & Product Marketing
Decklar
[email protected]
+1 (408) 461-5221

SOURCE Decklar

With a growing portfolio of standout consumer brands, the fund continues to fuel innovation and aims to back at least 50 more in the year ahead.

LOS ANGELES, Nov. 12, 2025 — SHOPLINE, the global commerce platform trusted by over 600,000 merchants, today announced the continued momentum of the Entrepreneur Ventures Consumer Labs Fund, an investment initiative designed to accelerate the next generation of CPG, wellness, and lifestyle brands, in partnership with Entrepreneur Ventures. The fund – powered by Entrepreneur Ventures’ media expertise and SHOPLINE’s commerce technology – has been actively supporting emerging consumer brands through strategic capital, infrastructure, and storytelling. By connecting global commerce technology with media-driven VC support, SHOPLINE and Entrepreneur Ventures are creating a next-generation ecosystem for early-stage founders to scale smarter and achieve breakout success.

The Entrepreneur Ventures Consumer Labs Fund represents an ongoing investment effort showcasing the success and momentum of its growing portfolio. From food rebels reinventing healthy snacking and hydration, to wellness makers reimagining recovery, to creators putting style and culture front and center, these brands aren’t waiting for permission to disrupt.

Brands supported by the Fund include:

Food & Beverage

• Dirty Dills – Boldly flavored pickles redefining snacking and specialty foods.
• Snazzy – Functional beverages crafted for focus, energy, and lifestyle enhancement.
• ōku Conscious Energy Gummy Snack – Plant-based, functional gummies delivering clean energy.
• Pricklee – A cactus water beverage brand bringing natural hydration to consumers.
• YATÉ – Sparkling yerba mate beverages delivering smooth, sustained energy from natural caffeine and antioxidants.
• Drink Mimosa – Ready-to-sip sparkling mimosas blending real juice and bubbly for a refreshing anytime celebration.

Health & Wellness

• Elos Thermal – Wellness-forward thermal therapy products for modern recovery.
• RemoBrush – Innovative toothbrush technology for healthier, smarter oral care.
• Miss Commando – Minimal-ingredient skincare essentials crafted with clean, active botanicals for healthy, confident skin.
• Commando Outdoor – Chemical-free, high-performance skincare engineered to protect military, first responders, and active men everywhere.

Fashion & Lifestyle

• Ales Grey – A purpose-driven footwear brand redefining modern style with sustainable materials and conscious design.
• AmorSui – Sustainable, stylish medical apparel designed for safety and empowerment.
• Culture Kicks – Sneakers and streetwear that fuse cultural expression with limited-edition style.

SHOPLINE offers merchants a fully integrated, all-in-one commerce platform—combining online, offline, and social selling, analytics, and payment solutions in a single, easy-to-use system. With advanced social commerce tools, seamless POS integration, and robust customization, SHOPLINE empowers brands of any size to launch, scale, and engage customers globally—future-proofing growth at every stage.

“We’re committed to removing barriers for founders—offering not just world-class technology but a true partnership with Entrepreneur Ventures, who bring hands-on mentorship, capital, and deep CPG expertise,” said Christopher Yang, Co-President of SHOPLINE. “Together, we unite comprehensive commerce tools, global reach, and practical operating support so brands can scale faster, smarter, and with the confidence that comes from best-in-class guidance.”

“At Entrepreneur Ventures, we believe the next wave of breakout brands needs more than capital—they need partners with global scale and real expertise,” said Jonathan Hung, Managing Partner of Entrepreneur Ventures. “That’s why teaming up with SHOPLINE is essential: their international footprint, integrated best-in-class technology, and social commerce and marketing power help founders move faster and scale smarter.”

Looking ahead, the Entrepreneur Ventures Consumer Labs Fund intends to continue seeking out additional strategic investments over the next 12 months, with a goal of funding at least 50 high-potential consumer brands.

To learn more about the Entrepreneur Ventures Consumer Labs Fund, visit https://entrepreneur.vc/ev-consumer-labs/

About SHOPLINE

Founded in 2013, SHOPLINE is a leading global Software-as-a-Service (SaaS) provider empowering retailers to sell, market, and operate their businesses on a unified commerce platform. SHOPLINE supports over 600,000 merchants worldwide with comprehensive solutions spanning e-commerce, social commerce, point-of-sale, and CRM. With an open platform architecture and thriving partner ecosystem, SHOPLINE delivers innovative technology and expert support so brands can build successful, differentiated commerce businesses in any market.

About Entrepreneur Ventures

Entrepreneur Ventures is a pre-seed venture capital fund launched by Entrepreneur Media, the publisher of Entrepreneur magazine and Entrepreneur.com. Entrepreneur Ventures invests $25,000–$100,000 in up to 200 high-potential startups across CPG, consumer tech, and frontier technology. Uniquely integrated with Entrepreneur Media’s platform, the fund provides portfolio companies unrivaled access to a large entrepreneurial audience, media visibility, and a collaborative angel network—amplifying brand presence and supporting growth beyond capital alone.

Media Contact:
Alyssa Scarpaci
[email protected] 

SOURCE SHOPLINE

Funding brings total raised to date over $10M; newly formed GC Advisory Board includes legal leaders from Bristol Myers Squibb, Docusign, HP, SentinelOne, GoDaddy, and more.

PALO ALTO, Calif., Nov. 12, 2025 — Theo Ai, the AI-driven prediction platform for Am Law 200 and General Counsels, today announced the formation of its General Counsel Advisory Board and a new round of funding led by Run Ventures, bringing the company’s total funding to date to over $10 million. The new round, which follows Theo’s $4.2 million seed raise in May 2025, will accelerate the company’s expansion of its AI capabilities, hiring of engineering talent, and continued development of its predictive analytics platform for the legal industry. PT Ungvichian, Partner at Run Ventures, will join Theo Ai’s Board of Directors as part of the investment.

Theo Ai’s Advisory Board brings together a cross-industry group of senior legal leaders to shape the company’s technology and guide adoption across enterprise legal departments. Members include GCs and CLOs. The Advisory Board strengthens trust and transparency between Theo and the legal community giving Fortune 500 Chief Legal Officers direct visibility into how Theo’s prediction models are built, validated, and applied. This trusted oversight ensures accuracy and accountability, so Theo’s technology meets the standards of the world’s most sophisticated legal teams. The founding members include:

• Sandra Leung (Former EVP, General Counsel at Bristol Myers Squibb)
• Jessica Nguyen (Deputy General Counsel, Docusign)
• Jared Sine (Chief Legal Officer, GoDaddy)
• Arthur Jenkins (In House Counsel, Regal Cinemas)
• Rob Hale (General Counsel, SmartBiz Bank)
• Tim Lee (Former Corporate Counsel, US Bank)
• Christophe Mosby (Associate General Counsel and VP, HP)
• Keenan Conder (Chief Legal Officer, SentinelOne, Inc.)
• Rachel Harris (General Counsel, Suzy, Inc.)
• Christopher Lalan (Chief Legal Officer, 1Money)
• Aruna Krishnamachari (Assistant General Counsel, eBay)
• Jeff Christianson (Former GC at F5 Networks, Nintex, Raptor)
• Jolene Marshall (Chief Legal Officer, HighLevel Inc.)
• Ross Weiner (Former Partner and General Counsel, Qatalyst Partners)
• Erica A. Holzer (Partner, Maslon LLP)

“The work of Theo Ai has the potential to revolutionize high-stakes litigation settlements,” said Sandra Leung, Former EVP and General Counsel at Bristol Myers Squibb. “It will expedite settlements and reduce legal expenses.”

“I’ve negotiated countless liability caps in contracts based on potential liability or comparable commercial terms of the industry,” said Jessica Nguyen, Deputy General Counsel, AI Innovation & Trust, at Docusign. “Theo transforms a theoretical risk to a number grounded in data.”

“Patrick and the Theo Ai team are setting a new pace for the legal industry. They’re tackling one of litigation’s biggest hurdles, uncertainty, by giving lawyers a clearer, data-driven view of the path ahead,” said PT Ungvichian, Partner at Run Ventures and Theo Ai’s new board member. “It’s the kind of ambition we love to run alongside, and we’re excited to help them and their exceptional advisors accelerate their vision.” 

“Just five months after closing our seed round, we’re excited to expand both our capital and advisors,” said Patrick Ip, Co-founder and CEO of Theo Ai. “We’re grateful for all the clients that have put their trust in us, and are excited by the expanding partnerships.”

Legal documents often stretch thousands of pages, Theo processes them in minutes while surfacing the facts that matter and providing an unprecedented level of case intelligence. Beyond the wealth of data in these files are the crucial case-specific nuances that Theo’s models are trained to tackle, understanding and weighing details like context, terminology, tone, and imagery. That vertical precision gives Theo an edge: it knows its clients’ legal environments better than anyone else. This is why vertical AI is the future and why general counsels are embracing Theo’s technology for the confidence it brings to every legal decision.

To learn more and join the waitlist for Theo Ai, visit: Theo Ai

About Theo Ai
Theo Ai is the first predictive engine designed by technical and legal professionals to forecast the outcome of legal disputes. Its AI models are trained on historical case data and incorporate real-time analytics with predictive modeling to deliver accurate and actionable insights. Theo Ai is meeting the most critical need for legal professionals — offering accurate case outcome predictions, backed by data. To learn more and join the waitlist for Theo Ai, visit https://theoai.ai/

About Run Ventures
Run Ventures is a Salt Lake City–based early-stage venture capital firm with a $290 million Fund IV focused on Series A and select Seed investments. The firm partners with founders building the future before anyone else sees it, backing bold bets in AI, the evolution of work, and edge computing. Investing in emerging innovation hubs beyond the coasts, Run Ventures works alongside entrepreneurs as true running partners, providing capital, guidance, and strategic support to help them go faster and further.

Media Contact:
Rick Medeiros
510-556-8517
[email protected] 

SOURCE Theo Ai

TEL AVIV, Israel, Nov. 12, 2025 — Corundum Neuroscience (CNS), the neuroscience venture builder and fund announced today they have participated in a Series A funding round for NextSense, a leader in wearable EEG technology helping consumers optimize brain health and sleep through Smartbuds. The investment will support NextSense’s next phase of growth as it prepares to bring its clinically-accurate in-ear EEG earbuds to market in Q4 2025.

“We are always looking for cutting-edge neuroscience solutions that improve brain health, making NextSense a perfect addition to our portfolio,” said Itsik Francis, PhD, Managing Partner, Business Development at Corundum Neuroscience. “We are excited to support the NextSense team to bring clinical-grade EEG monitoring to consumers, enabling them to better understand and improve their sleep.”

NextSense’s Smartbuds aim to deliver accurate sleep tracking while helping users unlock deeper, more restorative rest through auditory stimulation shown to boost slow-wave sleep by as much as 50% among early users. The buds use clinical-grade EEG technology to assess sleep stage and depth empowering users to better understand their sleep.

“We’re excited to partner with Corundum Neuroscience as we continue our work to democratize brain health. Their proven experience working with innovative neuroscience companies makes them an invaluable partner in launching Smartbuds to consumers everywhere,” said Jonathan Berent, Founder & CEO of NextSense.

About Corundum Neuroscience 

Corundum Neuroscience is a venture builder and fund advancing transformative neuroscience solutions from lab-to-life. The Corundum Neuroscience team combines deep domain expertise with a track-record of venture-building success to accelerate neuroscience solutions across the entire innovation lifecycle. Taking a long-term investment approach, Corundum Neuroscience helps researchers, entrepreneurs and startups develop life-changing solutions that target specific disease areas and outcomes to enhance people’s health, longevity and quality of life. Founded by former Joy Ventures executives, Corundum Neuroscience launched in September 2023, and is headquartered in Herzliya, Israel.

For company updates and information, follow Corundum Neuroscience on LinkedIn or visit: https://cnsfund.com. 

About NextSense

Based in Mountain View, CA, NextSense is redefining consumer wellness with the world’s first EEG earbuds. After years of research and clinical validation, the company created Smartbuds: a comfortable, everyday wearable that helps people sleep better, focus longer, and recharge more effectively. NextSense combines neuroscience and design to make brain health simple, accessible, and actionable.

Media Contact:  

Daniel Davis
FINN Partners for Corundum
[email protected]  

SOURCE Corundum Neuroscience

Led by New Enterprise Associates and Town Hall Ventures, new funding will enable company to expand to more specialties and continue its R&D investment in the industry’s first AI-enabled pharmacy management system

SAN FRANCISCO, Nov. 12, 2025 — House Rx, a health tech company focused on making specialty medications more accessible and affordable for patients, today announced it has raised $55 million in Series B equity and debt to expand its in-clinic specialty pharmacy model. The financing was led by New Enterprise Associates (NEA) and Town Hall Ventures and included participation from LRVHealth, First Round Capital, Bessemer Venture Partners, and Silicon Valley Bank. This new investment brings the company’s total capital raised to date to $100 million.

At a time when regulators and states are actively challenging the Pharmacy Benefit Manager (PBM)-owned, closed network specialty pharmacy model, House Rx offers an alternative vision – a nationwide network of locally owned, brick-and-mortar specialty dispensaries embedded in specialty clinics. The model puts patients and providers at the center and delivers vastly superior quality outcomes. By partnering with specialty clinics to integrate pharmacy services directly into care delivery, House Rx enables providers to offer high-touch, local alternatives to centralized pharmacy fulfillment models. This approach improves coordination between providers and pharmacists, reduces administrative complexity, and delivers better outcomes for patients dealing with complex conditions.

“There’s finally momentum behind creating a specialty pharmacy system that makes it easier for patients to seamlessly and more affordably access the medications they desperately need,” said Ogi Kavazovic, CEO & Founder of House Rx. “We’re seeing interest from stakeholders across the healthcare system — healthcare providers, manufacturers, payers, investors, and certainly employees who all recognize the opportunity to finally challenge the status quo in specialty pharmacy. We all want to do better by patients and help bring down the overwhelming expense to our healthcare system. With the support of this funding, we’re ready to scale operations to meet the exploding demand.”

To date, House Rx has partnered with more than 1,000 providers at 80 clinic sites nationwide, helping them stand up and successfully operate in-house pharmacies that deliver better outcomes for patients. House Rx processes approximately $1.5 billion in specialty scripts per year, with that volume expected to increase to $3 billion by the end of 2026.

“Specialty pharmacy is one of the highest-cost and least-transparent segments in healthcare and one that’s long overdue for change for the betterment of our healthcare system,” said Blake Wu, Partner at NEA. “NEA’s history of investing within specialty pharmacy and working with industry leaders in the category provides unique insight into its challenges, and we believe House Rx has an incredibly exciting vision to make a lasting change in this industry. The House Rx team is top notch, with a unique combination of specialty pharmacists and software builders working together to bring a new technology and service offering to market, making it cost effective for clinics to deliver complex specialty pharmacy services to their patients. We believe this model has the potential to change the landscape of specialty pharmacy for years to come.”

House Rx is the pharmacy management system of record for medically integrated dispensaries or pharmacies, and it comes with natively-embedded AI workflows. The tech platform is essential to driving the efficiencies and economies of scale required to succeed in this new model of local, decentralized pharmacy care. In April, House Rx announced their “Smart PA” AI feature, making prior authorizations in pharmacy 80% automated. The company is currently investing in several more AI capabilities which will come natively as part of its pharmacy management system.

“The House Rx platform blends software with clinical services, so patients start life-saving treatments in days, not weeks. With the need for improved patient access and adherence to medications, solutions like House Rx have never been more urgent,” said David Whelan, Co-Founder and General Partner at Town Hall Ventures. “We’re thrilled to support Ogi and his team of repeat healthcare and technology entrepreneurs in their mission to put providers and patients back in the center of the specialty pharmacy experience.”

About House Rx
House Rx  is a technology-enabled pharmacy services company focused on making specialty medication more accessible and affordable. The company helps clinics dispense specialty medications to their patients in a medically-integrated way using pharmacist expertise and modern technology. By helping physicians and pharmacists collaborate on patient care, House Rx is able to improve patient outcomes, lower the cost of care, and create a better experience for patients and their caregivers. Founded in 2021, House Rx is approaching 250 employees and was recently recognized by Time Magazine as one of the World’s Top HealthTech Companies of 2025.

About NEA
New Enterprise Associates, Inc.  (NEA) is a global venture capital firm focused on helping entrepreneurs build transformational businesses across multiple stages, sectors and geographies. Founded in 1977, NEA has over $25 billion in assets under management as of June 30, 2023 and invests in technology and healthcare companies at all stages in a company’s lifecycle, from seed stage through IPO. The firm’s long track record of investing includes more than 270 portfolio company IPOs and more than 450 mergers and acquisitions.

About Town Hall Ventures
Started in 2018 by former Optum Group Executive Vice President and head of the Centers for Medicare and Medicaid Services and Senior White House Advisor Andy Slavitt and long-time investor and company-builder David Whelan, Town Hall Ventures invests in companies that transform access and equitable care for underserved Americans. Its aim is to deliver top-quartile financial results by finding and scaling models that improve outcomes in communities left behind by the United States healthcare system. To date, Town Hall has started or invested in 42 companies, with 8 of the first 16 investments valued at over $1 billion.

Contact: [email protected]  

SOURCE House Rx

Arrived’s new rental property marketplace lets investors buy and sell shares of homes across the U.S., bringing stock market–style liquidity and flexibility to real estate investing

SEATTLE, Nov. 12, 2025 — Arrived, the leading platform for fractional real estate investing, today announced $27 million in new funding alongside the launch of the Arrived Secondary Market — a first-of-its-kind marketplace that enables investors to buy and sell shares of individual rental homes across the U.S. with just a few clicks.

This dual milestone marks a defining moment for both Arrived and the broader real estate industry, transforming real estate from a slow, offline transaction into a modern online experience — with tools for browsing, investing, and now trading shares of homes in just minutes.

More than 850,000 investors have joined Arrived, investing over $300 million in real estate assets spanning over 550 properties in 65 cities nationwide. In the first 3 weeks of trading, Arrived has seen investors place 57,000+ buy and sell orders.

These early results underscore how investors are actively using the platform to capture appreciation, rebalance portfolios, and access liquidity — behaviors that mirror the sophistication and efficiency of public markets.

“I love the audacity of the Arrived vision: a stock market for real estate,” said Ali Partovi, co-founder of Code.org and managing director of Neo, which has also backed Kalshi, Cursor, and Ramp. “I’m betting on them to democratize and digitize access to America’s $50 trillion in residential real estate.”

The new funding was led by Neo, with participation from Forerunner Ventures, Bezos Expeditions, Core, and additional strategic and community investments, bringing total new capital to $27 million and total funding to more than $60 million to date. Other existing investors include Marc Benioff, Spencer Rascoff, and Dara Khosrowshahi.

“We believe real estate investing is going to move online,” said Ryan Frazier, Co-Founder and CEO of Arrived. “Our vision is a future where real estate investing feels just like investing in public companies — where anyone can buy and sell shares of properties in minutes, not months.”

Through its peer-to-peer matching system, Arrived’s Secondary Market allows investors to:

• Buy and sell shares of rental properties directly from other real estate investors
• Exit or expand positions with greater flexibility—often in just minutes
• Capture appreciation and rebalance portfolios
• Access transparent pricing and seamless digital transactions

With investments starting at just $100, Arrived makes it possible for anyone to invest in real estate, earn passive income, and access potential appreciation without the hassles of traditional property management.

About Arrived
Arrived turns real estate into a modern, tradable asset. Think of it as the stock market for rental properties — where investors can buy shares in homes, earn rental income, and now sell those shares through the new Secondary Market.

Arrived is supported by world-class investors, including Neo, Bezos Expeditions, Marc Benioff, the founders of Warby Parker, Harry’s, and Allbirds, and Spencer Rascoff, former CEO of Zillow.  Learn more at Arrived.com

SOURCE Arrived

BOSTON, Nov. 12, 2025 — Modulight Biotherapeutics, developer of novel optogenetic platform for the treatment of neurological disorders, announced today the closing of its Seed funding round raising $12.2 million. The Seed round was led by Jibe Ventures and LocalGlobe, with participation from Nexus Neurotech Ventures, RedSeed VC, Secret Chord Ventures, Fresh Fund, Saras Capital, SilverArc Capital and Sha’ar Mivnim. The funding will enable the Company to accelerate the development of its optogenetic technology platform and advance its therapeutic product pipeline towards the clinic.

“This funding marks a significant milestone for Modulight Biotherapeutics as we advance our mission to develop light-based therapeutics for the treatments of severe neurological diseases,” said Yotam Eldar, MD, CEO, Modulight Biotherapeutics. “We welcome our partners and investors, underscoring their collective confidence in Modulight’s vision, strategy and innovative solution. The financial round will allow us to enhance the preclinical development of our optogenetic switch for the treatment of trigeminal pain and initiate IND-enabling studies, manufacturing and discussions with the FDA.”

“The brain is extraordinarily complex and we cannot continue to treat it nonspecifically. This investment validates our unique approach to performing precise circuit-based neuromodulation of the neural pathways underlying different neurological conditions. We’ve already seen very promising efficacy in multiple animal models of neurological disorders including pain, epilepsy, and movement disorders such as Parkinson’s disease and essential tremor. We believe our proprietary technology and therapeutic pipeline have the potential to transform the treatment of neurological disorders,” added Dr. Eldar.

“We are excited to invest in Modulight Biotherapeutics’ financing round,” said John Propst, PhD, MBA, Principal at Nexus NeuroTech Ventures. “At Nexus, we invest in breakthrough technologies at the intersection of neuroscience and engineering that have the potential to transform patient care. Modulight’s optogenetic neuromodulation platform represents a fundamentally new way to target neural circuits with cell-type and pathway-level precision—something long sought but until now technically out of reach. We believe the company’s scientific foundation, executional excellence, and vision position it to redefine how we treat neurological and neuropsychiatric disorders driven by neuronal hyperexcitability. We’re proud to support this exceptional team as they pioneer a new therapeutic modality in brain health.”

About Modulight Biotherapeutics Optogenetics Platform

Modulight Biotherapeutics develops cutting-edge technologies for precise, targeted treatment of neurological disorders by addressing dysfunctional neuronal activity exactly where and when it occurs.

Today’s treatments for neurological disorders – such as drugs, surgery, or electrical stimulation – act broadly, often affecting large brain regions or brain networks indiscriminately. Yet the brain is far from uniform: it is a complex network of more than 86 billion neurons organized into distinct circuits and pathways.

Our optogenetic technology represents a fundamental leap. By enabling selective expression of light-sensitive proteins (called opsins) in specific neurons, we can modulate their activity with light—targeting the right neurons, in the right place, at the right time. This allows us to precisely rebalance hyperexcited brain networks that drive debilitating disorders such as severe chronic pain, epilepsy, and movement disorders—all without damaging surrounding tissue or interfering with healthy brain function.

Our therapeutic platform is based on eOPN3¹, a proprietary, hypersensitive, and biostable inhibitory opsin designed for clinical use. eOPN3 exerts a robust inhibitory effect at the presynaptic terminal, enabling pathway-specific neuromodulation. This versatile therapeutic platform is being developed for a range of neurological diseases. Our early preclinical studies show that eOPN3-based treatment has high efficacy in multiple animal models of pain, epilepsy, and movement disorders. As proof of concept, eOPN3 is initially being investigated for the treatment of trigeminal pain, a severe and often drug-resistant facial pain disorder. For this indication, eOPN3 can be delivered directly into the trigeminal ganglion through a simple, outpatient procedure.

About Modulight Biotherapeutics

Modulight Biotherapeutics is pioneering a new era of medicine for people living with neurological disorders – one that is fast-acting, precise, and designed to provide real relief without side effects. The Company’s platform uses a unique approach for modulating neuronal activity using light-activated proteins that are specifically targeted to pathological cells and neural pathways. Modulight’s therapeutic platform is based on technology licensed from YEDA, the commercial arm of the Weizmann Institute of Science. For more information, please visit https://www.modulight.bio/

Media Contact: 

Tsipi Haitovsky
Global Media Liaison
+972-525-989892
[email protected]

¹ Mahn M. et al. Efficient optogenetic silencing of neurotransmitter release with a mosquito rhodopsin. Neuron, Volume 109, Issue 10, 1621 – 1635.e8

SOURCE Modulight Biotherapeutics

NEW YORK, Nov. 12, 2025 — Lucky Energy, one of the fastest-growing energy beverage brands in the U.S., announced today that it has successfully closed an oversubscribed $25 million Series B funding round, led by Paine Schwartz Partners. The round also saw continued support from existing investors, along with new backers including North Fifth Services, LLC, Sequel, and Joyance Partners, among others.

This investment highlights growing investor confidence in the rapidly expanding clean-energy beverage market, one of the fastest-growing segments in the $100 billion energy drink industry.

This new funding will fuel Lucky Energy’s nationwide growth, including expanding its retail presence, strengthening national and regional partnerships, increasing marketing efforts, and expanding its team as it continues to scale to meet rising consumer demand. The company also welcomed two Paine Schwartz Partners Operating Directors to its Board of Directors: James Brennan, founder and CEO of ENlightened Brand Ventures, and Bob DeBorde, Chairman of Suja Life and Promix Nutrition, bringing decades of experience building category leaders. With longtime board member Dan Ginsberg, former CEO of Red Bull North America, they form a best-in-class leadership team driving Lucky Energy’s expansion.

Founded with the mission to create energy drinks that are cleaner, simpler, and healthier, Lucky Energy offers a refreshing, functional energy drink made with just five ingredients- containing 0 sugar, 0 calories, and no artificial additives. The brand has quickly become a favorite among consumers seeking sustained, feel-good energy without the crash.

This funding follows the viral sellout launch of Lucky Energy’s Black Label line, available exclusively on its website. Building on the momentum of its award-winning flavors, the brand has seen breakout growth in 2025. It is now available in over 15,000 retail locations nationwide, with plans to expand into Walmart, Sheetz, and Cumberland Farms stores across the country in December. With sales on track to double year-over-year, Lucky Energy is poised to bring its clean energy mission to even more consumers.

“Lucky Energy is redefining what consumers expect from energy drinks,” said Bob DeBorde. “By combining great taste with clean, functional ingredients, the brand is positioned to lead the next wave of growth in the category.”

“Every now and again, a brand has an incredible story to tell. We, at Paine Schwartz Partners, think Richard’s and the story behind Lucky is one of the greatest of all time,” said James Brennan.

“Lucky Energy was born from two core beliefs: that people deserve a cleaner, simpler energy drink they can feel genuinely good about and that life is too short not to go all in on your biggest dreams. James Brennan launched Suja around the same time I started Kate Farms, and both brands went on to achieve extraordinary success. To now partner with James, along with Bob DeBorde, whose experience as SVP of US Sales & Operations at Coca-Cola and CEO of Suja brings unmatched expertise, is a full-circle moment and an incredible honor. Lucky Energy is one of the fastest-growing beverage brands in America, and we’re just getting started. We’re building a modern energy powerhouse, and our ambition is as bold as the people who drink Lucky,” said Richard Laver, Founder & CEO, Lucky Energy.

For more information, visit LuckyBevCo.com, check the store locator, and follow @LuckyEnergyOfficial on Instagram and @LuckyEnergy on TikTok.

About Lucky Energy
Lucky Energy is a simpler, better-for-you energy drink for those who believe success is built, not found. Founded by serial beverage visionary Richard Laver, Lucky Energy elevates performance with clean ingredients, bold natural flavor, and 33% fewer ingredients than traditional energy drinks. Each can is powered by a proprietary blend of 5 super-ingredients, including maca and beta-alanine, formulated to sharpen focus, boost endurance, and sustain drive. With 0 sugar, 0 calories, and 0 artificial additives, Lucky Energy fuels the athletes, creators, and everyday achievers who make their own luck—one intentional move at a time.

Lucky Energy is available online at LuckyBevCo.com, TikTok Shops, Amazon, and in more than 15,000 retail locations nationwide, including leading retailers in the Boston area such as Shaw’s and Star Market.

For press inquiries, please contact Valeria Carrasco directly at [email protected]

SOURCE Lucky Beverage Company